InvestorsHub Logo
icon url

yellow_bluff

07/25/13 12:33 PM

#11213 RE: KCSVEN #11207

also makes it more difficult and expensive for generics to compete. which supplier will be able to be as good as the four suppliers that AMRN has locked up and make pure EPA?

thus where would a new generic supplier come from, how much would it cost to get that supplier up to speed to be able to produce pure EPA and have the FDA sign off and what kind of profit could the generic supplier make if they are sole sourced with that supplier?

another decent hurdle.